Security key
89854M101
TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (TCRX)
CUSIP: 89854M101
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Voting Common Stock, $0.0001 par value per share
- Total 13F shares
- 34,291,369
- Total 13F value
- $272,339,183
- Share change
- +2,378,550
- SEC-reported price per share
- $7.94
- Number of holders
- 65
- Value change
- +$19,079,789
- Number of buys
- 38
- Number of sells
- 14
- Shares outstanding
- 55,838,719
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
65
Top holders
10
TCRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
TScan Therapeutics, Inc. SEC filings
TScan Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 89854M101
Recent filing periods:
Ownership snapshot
Top reported holders of TCRX - TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Lynx1 Capital Management LP
Disclosed value leader
Lynx1 Capital Management LP
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
3/4/5
Lead comparable stake: 9.4%
Showing 1-6 of 15 holder rows.
Quick read
Lynx1 Capital Management LP leads the comparable SEC ownership view at 9.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Lynx1 Capital Management LP's linked filing trail.
Comparable ownership
Top 5
Lynx1 Capital Management LP
9.4%
EcoR1 Capital, LLC
9%
ADAGE CAPITAL PARTNERS GP, L.L.C.
7%
BVF INC/IL
5.4%
BAKER BROS. ADVISORS LP
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP |
13F
Company
|
9.4%
|
$30,459,418
5,224,600 shares
|
— | 31 Dec 2023 |
| EcoR1 Capital, LLC |
13F
3/4/5
Company · 10%+ Owner
|
9%
|
$29,150,000
5,000,000 shares
|
— | 31 Dec 2023 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
7%
|
$22,737,000
3,900,000 shares
|
— | 31 Dec 2023 |
| BVF INC/IL |
13F
Company
|
5.4%
|
$17,428,633
2,989,474 shares
|
— | 31 Dec 2023 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
5%
|
$16,235,337
2,784,792 shares
|
— | 31 Dec 2023 |
| Propel Bio Management, LLC |
13F
Company
|
3.7%
|
$12,168,020
2,087,139 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
65
Shares
34,291,369
Rows available
65
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2026 Across Filers
Q1 2026 holders
59
Q1 2024 holders
65
Holder diff
6
| Investor | Q1 2026 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend